Pancreatic Adenosquamous Carcinoma clinical trials at UCSF
2 research studies open to eligible people
Pancreatic adenosquamous carcinoma is a rare cancer located in the pancreas. UCSF is researching if chemotherapy before and after surgery can better treat pancreatic cancer. UCSF is also studying a new chemotherapy plan for advanced cancer linked to certain genetic mutations.
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
open to eligible people ages 18 years and up
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy…
San Francisco, California and other locations
PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
open to eligible people ages 18 years and up
This phase II/III trial compares the effect of the 3-drug chemotherapy combination of nab-paclitaxel, gemcitabine, plus cisplatin versus the 2-drug chemotherapy combination of nab-paclitaxel plus gemcitabine for the treatment of patients with…
San Francisco, California and other locations
Our lead scientists for Pancreatic Adenosquamous Carcinoma research studies include Andrew H. Ko.
Last updated: